Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06899958 · ClinicalTrials.gov registry record · NA
Metabolism Enhancement by Laser Therapy
A NA study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT06899958: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT06899958 is a NA study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06899958, a NA study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a single-center, open-label pilot study to determine the effect of large area fractional laser treatment (LAFLT) on adults' metabolic profile.
Interventions
- DEVICE Fractional Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2027-01-01 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06899958
The ClinicalTrials.gov registry entry for NCT06899958 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fractional Laser is the first listed.
NCT06899958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06899958 about?
NCT06899958 is a clinical study titled "Metabolism Enhancement by Laser Therapy". This is a single-center, open-label pilot study to determine the effect of large area fractional laser treatment (LAFLT) on adults' metabolic profile.
What is the current status of trial NCT06899958?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2027-01-01. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT06899958?
The interventions under investigation include: Fractional Laser (DEVICE).
Who is sponsoring clinical trial NCT06899958?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.